Cargando…
Analysis of the cost-efficiency of the vascular impulse technology (VIT) in the perioperative management of complex ankle fractures: results of a prospective randomised controlled trial
INTRODUCTION: Posttraumatic swelling causes a delay in surgery, a prolonged hospital stay and a higher risk of complications. Thus, soft tissue conditioning following complex ankle fractures is of central importance in their perioperative management. Since the clinical benefit of VIT usage on the cl...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983194/ https://www.ncbi.nlm.nih.gov/pubmed/36864448 http://dx.doi.org/10.1186/s13018-023-03587-x |
_version_ | 1784900493904969728 |
---|---|
author | El Barbari, Jan S. Schnetzke, Marc Swartman, Benedict Grützner, Paul A. Franke, Jochen |
author_facet | El Barbari, Jan S. Schnetzke, Marc Swartman, Benedict Grützner, Paul A. Franke, Jochen |
author_sort | El Barbari, Jan S. |
collection | PubMed |
description | INTRODUCTION: Posttraumatic swelling causes a delay in surgery, a prolonged hospital stay and a higher risk of complications. Thus, soft tissue conditioning following complex ankle fractures is of central importance in their perioperative management. Since the clinical benefit of VIT usage on the clinical course has been shown, it should now be investigated whether it is also cost-efficient in doing so. MATERIALS AND METHODS: Included are published clinical results of the prospective, randomised, controlled, monocentric VIT study that have proven the therapeutic benefit in complex ankle fractures. Participants were allocated in a 1:1 ratio into the intervention group (VIT) and the control group (elevation). In this study, the required economic parameters of these clinical cases were collected on the data of the financial accounting and an estimation of annual cases had been performed to extrapolate the cost-efficiency of this therapy. The primary endpoint was the mean savings (in €). RESULTS: Thirty-nine cases were studied in the period from 2016 to 2018. There was no difference in the generated revenue. However, due to lower incurred costs in the intervention group, there were potential savings of about €2000 (p(ITT) = 0.073) to 3000 (p(AT) = 0.008) per patient compared to the control group with therapy costs decreasing as the number of patients treated increases from €1400 in one case to below €200 per patient in 10 cases. There were 20% more revision surgeries in the control group or 50 min more OR time, respectively, and an increased attendance by staff and medical personnel of more than 7 h. CONCLUSIONS: VIT therapy has been shown to be a beneficial therapeutic modality, but it is so not only in regard to soft-tissue conditioning but also cost efficiency. |
format | Online Article Text |
id | pubmed-9983194 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-99831942023-03-04 Analysis of the cost-efficiency of the vascular impulse technology (VIT) in the perioperative management of complex ankle fractures: results of a prospective randomised controlled trial El Barbari, Jan S. Schnetzke, Marc Swartman, Benedict Grützner, Paul A. Franke, Jochen J Orthop Surg Res Research Article INTRODUCTION: Posttraumatic swelling causes a delay in surgery, a prolonged hospital stay and a higher risk of complications. Thus, soft tissue conditioning following complex ankle fractures is of central importance in their perioperative management. Since the clinical benefit of VIT usage on the clinical course has been shown, it should now be investigated whether it is also cost-efficient in doing so. MATERIALS AND METHODS: Included are published clinical results of the prospective, randomised, controlled, monocentric VIT study that have proven the therapeutic benefit in complex ankle fractures. Participants were allocated in a 1:1 ratio into the intervention group (VIT) and the control group (elevation). In this study, the required economic parameters of these clinical cases were collected on the data of the financial accounting and an estimation of annual cases had been performed to extrapolate the cost-efficiency of this therapy. The primary endpoint was the mean savings (in €). RESULTS: Thirty-nine cases were studied in the period from 2016 to 2018. There was no difference in the generated revenue. However, due to lower incurred costs in the intervention group, there were potential savings of about €2000 (p(ITT) = 0.073) to 3000 (p(AT) = 0.008) per patient compared to the control group with therapy costs decreasing as the number of patients treated increases from €1400 in one case to below €200 per patient in 10 cases. There were 20% more revision surgeries in the control group or 50 min more OR time, respectively, and an increased attendance by staff and medical personnel of more than 7 h. CONCLUSIONS: VIT therapy has been shown to be a beneficial therapeutic modality, but it is so not only in regard to soft-tissue conditioning but also cost efficiency. BioMed Central 2023-03-02 /pmc/articles/PMC9983194/ /pubmed/36864448 http://dx.doi.org/10.1186/s13018-023-03587-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article El Barbari, Jan S. Schnetzke, Marc Swartman, Benedict Grützner, Paul A. Franke, Jochen Analysis of the cost-efficiency of the vascular impulse technology (VIT) in the perioperative management of complex ankle fractures: results of a prospective randomised controlled trial |
title | Analysis of the cost-efficiency of the vascular impulse technology (VIT) in the perioperative management of complex ankle fractures: results of a prospective randomised controlled trial |
title_full | Analysis of the cost-efficiency of the vascular impulse technology (VIT) in the perioperative management of complex ankle fractures: results of a prospective randomised controlled trial |
title_fullStr | Analysis of the cost-efficiency of the vascular impulse technology (VIT) in the perioperative management of complex ankle fractures: results of a prospective randomised controlled trial |
title_full_unstemmed | Analysis of the cost-efficiency of the vascular impulse technology (VIT) in the perioperative management of complex ankle fractures: results of a prospective randomised controlled trial |
title_short | Analysis of the cost-efficiency of the vascular impulse technology (VIT) in the perioperative management of complex ankle fractures: results of a prospective randomised controlled trial |
title_sort | analysis of the cost-efficiency of the vascular impulse technology (vit) in the perioperative management of complex ankle fractures: results of a prospective randomised controlled trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983194/ https://www.ncbi.nlm.nih.gov/pubmed/36864448 http://dx.doi.org/10.1186/s13018-023-03587-x |
work_keys_str_mv | AT elbarbarijans analysisofthecostefficiencyofthevascularimpulsetechnologyvitintheperioperativemanagementofcomplexanklefracturesresultsofaprospectiverandomisedcontrolledtrial AT schnetzkemarc analysisofthecostefficiencyofthevascularimpulsetechnologyvitintheperioperativemanagementofcomplexanklefracturesresultsofaprospectiverandomisedcontrolledtrial AT swartmanbenedict analysisofthecostefficiencyofthevascularimpulsetechnologyvitintheperioperativemanagementofcomplexanklefracturesresultsofaprospectiverandomisedcontrolledtrial AT grutznerpaula analysisofthecostefficiencyofthevascularimpulsetechnologyvitintheperioperativemanagementofcomplexanklefracturesresultsofaprospectiverandomisedcontrolledtrial AT frankejochen analysisofthecostefficiencyofthevascularimpulsetechnologyvitintheperioperativemanagementofcomplexanklefracturesresultsofaprospectiverandomisedcontrolledtrial |